tradmap

CRBP Earnings Corbus Pharmaceuticals Holdings, Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$11 -$6 $0 2021 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $18M $36M 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$111M -$56M $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$9 -$4 $0 Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26
EPS
Net income (quarterly)
-$35M -$18M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income
Return on equity (quarterly)
-3222% -1553% 116% 0% Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
ROE

Reported EPS history

1–23 of 23
Q2 20262026-06-30-3.042026-08-0610-Q
Q1 20262026-03-31-1.232026-05-1210-Q
FY 20252025-12-31-5.902026-03-0910-K
Q3 20252025-09-30-4.732025-11-1210-Q
Q2 20262025-06-30-2.832026-08-0610-Q
Q1 20262025-03-31-1.392026-05-1210-Q
FY 20252024-12-31-3.682026-03-0910-K
Q3 20252024-09-30-2.922025-11-1210-Q
Q2 20252024-06-30-1.752025-08-0510-Q
Q1 20252024-03-31-0.832025-05-0610-Q
FY 20242023-12-31-10.312025-03-1110-K
Q3 20242023-09-30-8.522024-11-0710-Q
Q2 20242023-06-30-6.272024-08-0610-Q
Q1 20242023-03-31-4.242024-05-0710-Q
FY 20232022-12-31-10.152024-03-1210-K
Q3 20232022-09-30-7.552023-11-0710-Q
Q2 20232022-06-30-5.442023-08-0810-Q
Q1 20232022-03-31-2.262023-05-0910-Q
FY 20222021-12-31-11.152023-03-0710-K
Q3 20222021-09-30-0.292022-11-0810-Q
Q2 20202020-06-30-0.952020-08-0610-Q
Q2 20202019-06-30-0.382020-08-0610-Q
Q2 20192018-06-30-0.422019-08-0810-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.